Weill Cornell Internal Medicine Associates
New York, 10021, United States
NCT Number: NCT00603070
The purpose of this study is twofold:
1. to measure the effects of transitioning from one electronic prescribing system to another in the ambulatory setting on medication errors and human-computer interactions 2. to evaluate the impact of electronic transmission of discharge medication lists to the ambulatory setting on medication discrepancies and adverse drug events
Looking for future studies?
Notify MeAll sexes
Observational
New York, 10021, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Transition from home-grown to vendor-based ambulatory e-prescribing systems
Other names: WebCIS, CLIMACS, EpicCare, Eclypsis
Patient discharge medication lists will be transmitted upon discharge from their inpatient medical record to their outpatient medical record and their outpatient provider will be notified of this transmission.
Time frame: 2 weeks prior, 3 months, 1 year after intervention and 2 years after intervention
Time frame: 30 days after patient is discharged from hospital
Time frame: 30 days after patient hospital discharge
Time frame: 3 months after intervention
Weill Medical College of Cornell University
Other
Electronic Prescribing and Electronic Transmission of Discharge Medication Lists to Improve Ambulatory Medication Safety
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03338725
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Medellín, Antioquia, Colombia
View Trial DetailsNCT00773942
Adverse Effects, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT00225576
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Boston, Massachusetts, United States
View Trial DetailsNCT07711704
Education, Nursing, Medication Errors
Beykoz, Istanbul, Turkey (Türkiye)
View Trial Details